2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS

VE6142019000581SUndetermined Publication Date: 2022-02-17MERCK SHARP & DOHME CORP
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
MERCK SHARP & DOHME CORP
Filing Date
2019-10-31
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

The novel compounds of structural formula (I), and their pharmaceutically acceptable salts, are inhibitors of NAV1.8 channel activity and may be useful in the treatment, prevention, management, improvement, control, and suppression of diseases mediated by NAV1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention, or management of pain disorders, cough disorders, acute itching disorders, and chronic itching disorders.